The most important decisions in biotech are still:
Before
Weeks of Scattered Work The KRAS G12C assessment lived across a biology team's spreadsheets, email threads, slide decks, and lab notebook excerpts. The team could assemble the story - but not prove how each conclusion was reached.

After
One Structured Decision Packet Cell-line data, biomarker rationale, selectivity insights, and expert judgment are all linked directly to each claim. Reviewers can move from any conclusion to the exact supporting evidence in one step. Governance-Ready by Default Rubric scores, reviewer comments, approval history, and version diffs sit in the same record - making it easy to defend the call, or challenge it with precision. Revisitable as New Data Arrives When new data changes the picture, a new version of the packet is created. The previous assessment is preserved, the new reasoning is added, and the full decision history remains intact.

Same science. Completely different clarity
Scientific R&D has changed. Discovery teams now have access to more data, more models, more publications, more computational outputs, and more AI-assisted recommendations than any previous generation of scientists. But the way teams make decisions has not changed nearly enough.